Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Net Margin (2016 - 2026)

Orthofix Medical has reported Net Margin over the past 17 years, most recently at 11.23% for Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 1800.0% year-over-year to 11.23%, compared with a TTM value of 4.2% through Mar 2026, up 2352.0%, and an annual FY2025 reading of 0.13%, up 1698.0% over the prior year.
  • Net Margin came in at 11.23% for Q1 2026, down from 41.4% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 90.14% in Q4 2023 to a low of 37.56% in Q1 2023.
  • Median Net Margin over the past 5 years was 11.76% (2025), compared with a mean of 5.61%.
  • The sharpest move saw Net Margin soared 10069bps in 2023, then crashed -10792bps in 2024.
  • Over 5 years, Net Margin stood at 10.55% in 2022, then soared by 955bps to 90.14% in 2023, then crashed by -120bps to 17.78% in 2024, then soared by 333bps to 41.4% in 2025, then plummeted by -127bps to 11.23% in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Net Margin are 11.23% (Q1 2026), 41.4% (Q4 2025), and 11.76% (Q3 2025).